Ochs, Madeleine A.
Marini, Bernard L.
Perissinotti, Anthony J.
Foucar, Charles E.
Pettit, Kristen
Burke, Patrick
Bixby, Dale L.
Benitez, Lydia L.
Article History
Received: 20 April 2022
Accepted: 13 May 2022
First Online: 26 May 2022
Declarations
:
: This article does not contain any studies with human participants performed by any of the authors.
: Kristen Pettit, MD, provides advising for the following companies: Kura Oncology, PharmaEssentia, CTI Biopharma. Anthony J. Perissinotti, PharmD, is a consultant for Servier, Amgen, and Pfizer pharmaceuticals. Bernard L. Marini, PharmD, is a consultant for Servier. None of the other authors has any conflicts of interest to disclose.